Edition:
United States

Cogentix Medical Inc (CGNT.OQ)

CGNT.OQ on NASDAQ Stock Exchange Capital Market

2.89USD
23 Feb 2018
Change (% chg)

$-0.06 (-2.03%)
Prev Close
$2.95
Open
$2.96
Day's High
$2.98
Day's Low
$2.85
Volume
12,678
Avg. Vol
10,895
52-wk High
$3.33
52-wk Low
$1.55

Chart for

About

Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC... (more)

Overall

Beta: 0.81
Market Cap(Mil.): $176.02
Shares Outstanding(Mil.): 60.91
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 30.84 16.31
EPS (TTM): -- -- --
ROI: -- 9.68 35.74
ROE: -- 14.23 17.71

BRIEF-Cogentix Medical Sees FY 2017 Revenue Up About 9 Percent

* COGENTIX MEDICAL ANNOUNCES 17% PRELIMINARY FOURTH QUARTER 2017 YEAR-OVER-YEAR REVENUE GROWTH

Feb 06 2018

BRIEF-Cogentix Medical Announces Palmetto GBA Extends Medicare Coverage on Urgent PC

* COGENTIX MEDICAL - PALMETTO GBA EXTENDED ITS COVERAGE POLICY FOR PERCUTANEOUS TIBIAL NERVE STIMULATION Source text for Eikon: Further company coverage:

Dec 06 2017

BRIEF-Cogentix Medical Q3 revenue rose 3 percent

* Cogentix Medical reports third quarter results; second highest quarterly revenue in company history

Nov 07 2017

Competitors

  Price Chg
Olympus Corp (7733.T) ¥4,140 +20.00
Baxter International Inc (BAX.N) $68.36 +0.93
Pfizer Inc. (PFE.N) $36.26 +0.52
Johnson & Johnson (JNJ.N) $132.02 +2.11
Novartis AG (NOVN.S) CHF79.38 -0.60
GlaxoSmithKline plc (GSK.L) 1,296.00 -7.00

Earnings vs. Estimates